NovoCure
NVCR
NVCR
176 hedge funds and large institutions have $2.9B invested in NovoCure in 2018 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 64 increasing their positions, 59 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
9% more funds holding
Funds holding: 161 → 176 (+15)
1.48% more ownership
Funds ownership: 58.33% → 59.81% (+1.5%)
8% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 59
Holders
176
Holding in Top 10
6
Calls
$63.9M
Puts
$16.2M
Top Buyers
| 1 | +$156M | |
| 2 | +$72M | |
| 3 | +$43.2M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$27.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25M |
Top Sellers
| 1 | -$32.1M | |
| 2 | -$24.5M | |
| 3 | -$24.3M | |
| 4 |
SG
StepStone Group
La Jolla,
California
|
-$23.6M |
| 5 |
PC
PointState Capital
New York
|
-$22.5M |